Latest News and Press Releases

BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc. (Imbria), a clinical-stage company developing innovative therapeutics for cardiovascular diseases, today announced that the...

Thanks to the support of the Linda and Mike Mussallem Foundation, Octane has launched the Octane Mussallem Cardiovascular Accelerator.

Austin, TX, USA, June 09, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Generic Drug Market Size, Trends and Insights By Brand (Branded generic drugs,...

CHENGDU, China and ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced today that the US FDA granted...

Final results confirm and build on interim BIRCH results in 23 ICH patients Primary safety endpoint met with no mortality observedEncouraging efficacy signals on all clinical and biomarker endpoints...

Final results of BIRCH multicenter, randomized, open-label Phase 2a proof-of-concept BIRCH trial with 23 patients, conducted in BelgiumFinal results build on positive second interim results announced...

Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with...

SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced the...

Grace E. Colón, Ph.D., Appointed Chair of the Board of Directors John Glasspool Appointed Board Director Lekhan Shivashankar Appointed Chief of Staff New Additions Strengthen Aronora as it Advances...

Imbria extends Series B financing with new investor AXA IM Alts to advance ninerafaxstat and address urgent global cardiovascular health challenges.